These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 15699114)
41. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105 [TBL] [Abstract][Full Text] [Related]
42. Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP. Ruedl C; Storni T; Lechner F; Bächi T; Bachmann MF Eur J Immunol; 2002 Mar; 32(3):818-25. PubMed ID: 11870626 [TBL] [Abstract][Full Text] [Related]
43. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. Desai DD; Harbers SO; Flores M; Colonna L; Downie MP; Bergtold A; Jung S; Clynes R J Immunol; 2007 May; 178(10):6217-26. PubMed ID: 17475849 [TBL] [Abstract][Full Text] [Related]
44. TAP-dependent major histocompatibility complex class I presentation of soluble proteins using listeriolysin. Darji A; Chakraborty T; Wehland J; Weiss S Eur J Immunol; 1997 Jun; 27(6):1353-9. PubMed ID: 9209484 [TBL] [Abstract][Full Text] [Related]
45. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. Shibagaki N; Udey MC J Immunol; 2002 Mar; 168(5):2393-401. PubMed ID: 11859130 [TBL] [Abstract][Full Text] [Related]
46. Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA. Kuchtey J; Chefalo PJ; Gray RC; Ramachandra L; Harding CV J Immunol; 2005 Aug; 175(4):2244-51. PubMed ID: 16081792 [TBL] [Abstract][Full Text] [Related]
47. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504 [TBL] [Abstract][Full Text] [Related]
48. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. Pooley JL; Heath WR; Shortman K J Immunol; 2001 May; 166(9):5327-30. PubMed ID: 11313367 [TBL] [Abstract][Full Text] [Related]
49. Lectin-like oxidized low-density lipoprotein receptor-1 delivers heat shock protein 60-fused antigen into the MHC class I presentation pathway. Xie J; Zhu H; Guo L; Ruan Y; Wang L; Sun L; Zhou L; Wu W; Yun X; Shen A; Gu J J Immunol; 2010 Aug; 185(4):2306-13. PubMed ID: 20631313 [TBL] [Abstract][Full Text] [Related]
50. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Brossart P; Bevan MJ Blood; 1997 Aug; 90(4):1594-9. PubMed ID: 9269778 [TBL] [Abstract][Full Text] [Related]
56. The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells. Liu X; Lu L; Yang Z; Palaniyandi S; Zeng R; Gao LY; Mosser DM; Roopenian DC; Zhu X J Immunol; 2011 Apr; 186(8):4674-86. PubMed ID: 21402891 [TBL] [Abstract][Full Text] [Related]
57. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells. Stober D; Trobonjaca Z; Reimann J; Schirmbeck R Eur J Immunol; 2002 Apr; 32(4):1099-108. PubMed ID: 11920577 [TBL] [Abstract][Full Text] [Related]
58. Intracellular routes and selective retention of antigens in mildly acidic cathepsin D/lysosome-associated membrane protein-1/MHC class II-positive vesicles in immature dendritic cells. Lutz MB; Rovere P; Kleijmeer MJ; Rescigno M; Assmann CU; Oorschot VM; Geuze HJ; Trucy J; Demandolx D; Davoust J; Ricciardi-Castagnoli P J Immunol; 1997 Oct; 159(8):3707-16. PubMed ID: 9378956 [TBL] [Abstract][Full Text] [Related]